101 related articles for article (PubMed ID: 21928112)
1. The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.
Cecener G; Tunca B; Egeli U; Bekar A; Tezcan G; Erturk E; Bayram N; Tolunay S
Cell Mol Neurobiol; 2012 Mar; 32(2):237-44. PubMed ID: 21928112
[TBL] [Abstract][Full Text] [Related]
2. Preferential
Giger OT; Ten Hoopen R; Shorthouse D; Abdullahi S; Bulusu VR; Jadhav S; Maher ER; Casey RT
J Clin Pathol; 2023 Dec; 77(1):34-39. PubMed ID: 36198483
[TBL] [Abstract][Full Text] [Related]
3. Molecular epigenetics and genetics in neuro-oncology.
Nagarajan RP; Costello JF
Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
[TBL] [Abstract][Full Text] [Related]
4. Integrative multi-omics characterization reveals sex differences in glioblastoma.
Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
[TBL] [Abstract][Full Text] [Related]
5. Seasonality modifies methylation profiles in healthy people.
Ricceri F; Trevisan M; Fiano V; Grasso C; Fasanelli F; Scoccianti C; De Marco L; Tos AG; Vineis P; Sacerdote C
PLoS One; 2014; 9(9):e106846. PubMed ID: 25210735
[TBL] [Abstract][Full Text] [Related]
6. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.
Fedele V; Dai F; Masilamani AP; Heiland DH; Kling E; Gätjens-Sanchez AM; Ferrarese R; Platania L; Soroush D; Kim H; Nelander S; Weyerbrock A; Prinz M; Califano A; Iavarone A; Bredel M; Carro MS
Mol Cancer Res; 2017 Aug; 15(8):998-1011. PubMed ID: 28512252
[TBL] [Abstract][Full Text] [Related]
8. Recurrent epimutations activate gene body promoters in primary glioblastoma.
Nagarajan RP; Zhang B; Bell RJ; Johnson BE; Olshen AB; Sundaram V; Li D; Graham AE; Diaz A; Fouse SD; Smirnov I; Song J; Paris PL; Wang T; Costello JF
Genome Res; 2014 May; 24(5):761-74. PubMed ID: 24709822
[TBL] [Abstract][Full Text] [Related]
9. CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma.
Belut DR; Lima EO; Zanini MA; Galvani AF; Furtado FB; Ferrasi AC
Eur J Cancer Prev; 2024 Jan; 33(1):73-btii. PubMed ID: 37401481
[TBL] [Abstract][Full Text] [Related]
10. Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL).
Mohammad F; Pandith AA; Rasool SUA; Guru FR; Qasim I; Geelani S; Nisar S; Baba SM; Ganie FA; Kouser S; Rasool J
Discov Oncol; 2024 Apr; 15(1):108. PubMed ID: 38587694
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Targeting of Glioblastoma.
Romani M; Pistillo MP; Banelli B
Front Oncol; 2018; 8():448. PubMed ID: 30386738
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes.
Sakthikumar S; Roy A; Haseeb L; Pettersson ME; Sundström E; Marinescu VD; Lindblad-Toh K; Forsberg-Nilsson K
Genome Biol; 2020 Jun; 21(1):127. PubMed ID: 32513296
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma.
Pratap UP; Sareddy GR; Liu Z; Venkata PP; Liu J; Tang W; Altwegg KA; Ebrahimi B; Li X; Tekmal RR; Viswanadhapalli S; McHardy S; Brenner AJ; Vadlamudi RK
Neurooncol Adv; 2021; 3(1):vdab099. PubMed ID: 34485908
[TBL] [Abstract][Full Text] [Related]
14. Morphological and Molecular Biological Characteristics of Experimental Rat Glioblastoma Tissue Strains Induced by Different Carcinogenic Chemicals.
Sentyabreva A; Miroshnichenko E; Artemova D; Alekseeva A; Kosyreva A
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672069
[TBL] [Abstract][Full Text] [Related]
15. microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.
Tezcan G; Tunca B; Bekar A; Preusser M; Berghoff AS; Egeli U; Cecener G; Ricken G; Budak F; Taskapılıoglu MO; Kocaeli H; Tolunay S
Cell Mol Neurobiol; 2014 Jul; 34(5):679-92. PubMed ID: 24691539
[TBL] [Abstract][Full Text] [Related]
16. HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the
Hu C; Peng K; Wu Q; Wang Y; Fan X; Zhang DM; Passerini AG; Sun C
Theranostics; 2021; 11(11):5605-5619. PubMed ID: 33859766
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of ceRNA network and DNA methylation associated with gene expression in malignant pheochromocytomas: a study based on The Cancer Genome Atlas.
Zhang J; Cong R; Zhang Q; Zeng T; Song R; Meng X
Transl Androl Urol; 2020 Apr; 9(2):344-354. PubMed ID: 32420140
[TBL] [Abstract][Full Text] [Related]
18. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review.
Wu X; Wu G; Yao X; Hou G; Jiang F
Drug Des Devel Ther; 2016; 10():699-709. PubMed ID: 26929601
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.
Yan W; Xu N; Han X; Zhou XM; He B
Sci Rep; 2016 Jan; 6():19303. PubMed ID: 26796853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
